Children with severe bacterial infections in intensive care
Part of Infections clinical trials.
This trial looks at how children with severe bacterial infections that start outside the hospital are treated in the pediatric intensive care unit. It helps doctors learn more about these infections to improve care for kids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is under 18 years old and currently in the hospital.
- Your child has a severe bacterial infection that started outside the hospital (not caught while already in the hospital).
- The infection is confirmed by finding bacteria in a normally sterile area of the body (like blood or spinal fluid).
- Your child is being treated in a pediatric intensive care unit (PICU).
- You (the parent) and your child (if old enough) agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people under 18 who have a confirmed invasive Group A strep infection, meaning strep bacteria found in places that are normally sterile (like the blood or deep tissues). It tests whether a specific study approach can help improve outcomes for children with these serious infections.
This trial enrolls children in the pediatric intensive care unit (PICU) who have a severe infection. It aims to better understand germs and drug resistance so future treatments can be more effective.
This study checks children in pediatric intensive care for possible “immune system problems” after a severe infection. The goal is to find primary immunodeficiencies early, which may change follow-up and treatment for the child’s immune health.
This study looks at serious bacterial infections in children with sickle cell disease in France from 2020 to 2025. Researchers want to understand which infections happen most often and how they're treated, to help improve care for children with sickle cell disease.
This trial measures how anti-infective medicines move through a child’s body while they are in the hospital or during follow-up. The goal is to better understand dosing and drug exposure in critically ill children.
This study tracks cases of invasive pneumococcal disease (a serious infection) in children and newborns. It may help clinicians better understand how these infections happen and guide future prevention and treatment.
Hear when a new Hospitalized Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.